News

Proprio's Paradigm Wins 2025 Fast Company Award for Innovation

Proprio's Paradigm Wins 2025 Fast Company Award for Innovation

Proprio Paradigm Earns Fast Company's 2025 World Changing Ideas Award

Proprio, a leader in AI-powered surgical technology, proudly announces that its advanced system, Paradigm, has received the prestigious recognition from Fast Company with the 2025 World Changing Ideas Award. This accolade honors groundbreaking innovations that address pressing global challenges.

Transforming Surgical Procedures with AI

Paradigm stands out as a revolutionary surgical guidance platform utilizing advanced AI and computer vision technologies. It has recently gained its second major 510(k) clearance from the U.S. FDA, significantly enhancing its capabilities by integrating intraoperative measurements. For the first time, surgeons can achieve 3D, real-time, and segmental visualization of anatomy, enabling them to adhere to surgical plans with measurable precision.

The Art of Possibility

Fast Company's editor-in-chief, Brendan Vaughan, remarked, "The World Changing Ideas Awards showcase what is possible. We celebrate those making meaningful differences in tackling our world's biggest issues." This underscores the importance of recognizing innovations that propel forward societal benefits.

Proprio's Vision for Future of Healthcare

According to Gabriel Jones, CEO and Founder of Proprio, healthcare must transition from a manual approach to a digital, automated future that leverages intelligent systems to serve billions globally. Proprio's Paradigm is designed to be the first surgical operating system powered by an advanced multi-modal foundational model that will redefine surgical practice.

AI-Driven Surgical Intelligence

With the ambitious goal of aggregating worldwide surgical expertise, Proprio aims to create an intelligent repository accessible to surgical teams at any moment. This AI-first approach will revolutionize patient treatment pathways, enhancing imaging, diagnostics, planning, and performance during surgeries by providing real-time guidance coupled with in-depth analytics.

Recognition and Impact in the Industry

Jones emphasized how Paradigm will foster a broad array of applications that enhance patient outcomes and improve healthcare provider experiences. He remarked, "Winning this award reinforces the significance of our work and vision for the future of surgical technology."

About Proprio

Proprio leads in AI-based surgical technology, with its flagship product, the Proprio Paradigm platform. This innovative solution dramatically transforms surgical practices, delivering AI-guided visualizations and actionable insights that elevate precision, improve efficiency, and enhance patient recovery rates. Contributions from over 200 leading neuro and orthopedic surgeons have shaped Proprio's advancements. Find more information at proprio.ai.

About Fast Company

Fast Company represents a media brand dedicated to exploring the intersection of business, innovation, and design. It engages influential leaders and innovators to discuss the evolution of business practices. Fast Company publishes insightful content and is part of Mansueto Ventures LLC, alongside its sister publication, Inc. Learn more at www.fastcompany.com.

Frequently Asked Questions

What is the Proprio Paradigm?

The Proprio Paradigm is an AI-powered surgical guidance platform that enhances surgical procedures through advanced visualization and real-time data.

What award did Proprio Paradigm win?

Proprio Paradigm won the 2025 World Changing Ideas Award from Fast Company for its innovative impact on healthcare.

How does Proprio Paradigm improve surgeries?

It provides 3D, real-time visualization and allows surgeons to measure surgical progress objectively, enhancing overall precision.

Who founded Proprio?

Proprio was founded by Gabriel Jones, who aims to innovate surgical technology for improved patient care.

What is the vision of Proprio?

Proprio envisions an automated healthcare future where AI and data play crucial roles in surgical practices, enhancing outcomes for patients worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 225

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 242

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 135

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 222

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Bouygues Enhances Shareholder Value Through Buyback Actions

Updated Category News Views 74

Bouygues Boosts Shareholder Value with Buyback Initiatives In corporate finance, share buybacks are often adopted as a strategic way to strengthen shareholder trust and increase stock value. Recently, Bouygues SA's trading activities have shown their dedication to creating value and aligning with the interests of their shareholders. Summary of Recent Buyback Activities...

Continue Reading
Warren Buffett's Investment in Occidental Faces Major Setback

Updated Category News Views 61

Warren Buffett's Investment Challenges with Occidental Petroleum Recently, Occidental Petroleum's shares dropped by 29% since mid-April, which has a direct impact on Warren Buffett’s large investment in the company. This decline raises concerns about potential strategies for future investments. Investment Context and Current Situation Chris Bloomstran, an experienced...

Continue Reading
Datavault AI Boosts WiSA Technology for Enhanced Home Audio

Updated Category News Views 275

Enhancing Audio Experience with Datavault AI's Innovations In the ever-evolving world of audio technology, Datavault AI has made significant strides to enhance the home audio experience. Through its Acoustic Science Division's Wireless Sound Association (WiSA), the company has launched several cutting-edge solutions designed to elevate audio quality while maintaining...

Continue Reading
Turkey Central Bank's Recent Interest Rate Reduction Explained

Updated Category News Views 297

Turkey's Central Bank Interest Rate Adjustment The central bank of Turkey has recently made headlines by announcing a significant reduction in its interest rate for the second consecutive time. This move is primarily attributed to a more pronounced slowdown in inflation that has taken place recently. Rate Cut Details The Monetary Policy Committee, led by the governor, has...

Continue Reading
Embracing Inclusivity: The Proud Pair Jewelry Initiative

Updated Category News Views 350

Embracing Inclusivity: The Proud Pair Jewelry Initiative In a significant step towards inclusivity, Hong Kong Marriage Equality has joined forces with the innovative local jewellery brand Playback Concept to unveil the "Proud Pair" collection. This unique initiative reimagines traditional jewellery by incorporating essential motifs that resonate with diverse gender...

Continue Reading